NASDAQ$DFTX

Definium Therapeutics Inc · Q3 2017 earnings

Q3 2017 earnings · · Investor relations

Headline financials

EPS (adj)

-$1.67

No prior period
Net Income

-$513K

No prior period
Operating Income

-$223K

No prior period
Gross Profit

-$5.64K

No prior period
R&D Expense

$0.00

No prior period

Revenue & EPS history

MindMed · Revenue · Quarterly

$0

Q2 2025
Beat estimate in 0 of 1 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2017

Historical avgQ3 2017

+0.8%

Avg return

Earnings day

+2.9%

Avg return

5 days after

+3.0%

Avg return

30 days after

44%

14 / 32 earnings

Positive

+25.8%

Q3 2024

Best reaction

-25.0%

Q1 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+0.9%+2.7%+3.4%
Q3 2025+3.2%+7.1%+8.9%
Q2 2025-7.3%+8.8%-2.3%
Q1 2025+4.4%+6.5%+26.2%
Q4 2024+3.6%-0.7%-14.9%
Q3 2024+25.8%+21.3%+10.2%
Q1 2024-4.5%-11.5%-24.1%
Q4 2023+2.9%+12.2%+69.1%
Q3 2023+24.1%+13.3%+41.4%
Q2 2023-5.2%-5.4%-10.5%
Q1 2023-7.6%-10.8%-6.4%
Q4 2022-9.9%-8.1%-12.3%
Q3 2022+19.9%+18.7%+9.5%
Q2 2022+11.3%+4.3%-15.0%
Q1 2022-0.8%-1.2%-2.3%
Q4 2021+0.0%-9.3%-30.9%
Q4 2020-7.0%-7.7%-5.8%
Q3 2020+8.2%+13.3%+28.8%
Q2 2020+14.9%+5.7%-9.2%
Q1 2020+4.5%-5.2%+2.0%
Q3 2019-13.7%-13.7%+29.4%
Q2 2019+0.0%+33.3%+11.1%
Q1 2019-25.0%+38.3%-1.7%
Q4 2018-1.9%-3.7%+11.1%
Q3 2018-4.2%+4.2%-12.5%
Q2 2018-0.9%-6.0%-39.6%
Q1 2018-8.4%-9.8%-15.8%
Q4 2017-4.4%+0.0%+2.4%
Q3 2017+1.6%+9.6%-2.7%
Q2 2017-1.9%-7.5%-0.4%
Q1 2016+1.5%-6.4%-10.1%
Q4 2016+0.0%+0.0%+58.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro